98 related articles for article (PubMed ID: 16461311)
21. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy.
Ling PD; Vilchez RA; Keitel WA; Poston DG; Peng RS; White ZS; Visnegarwala F; Lewis DE; Butel JS
Clin Infect Dis; 2003 Nov; 37(9):1244-9. PubMed ID: 14557970
[TBL] [Abstract][Full Text] [Related]
23. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
24. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
Almeida M; Cordero M; Almeida J; Orfao A
Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
[TBL] [Abstract][Full Text] [Related]
25. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
Martin SI; Zukerberg L; Robbins GK
Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
[TBL] [Abstract][Full Text] [Related]
26. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
27. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S
Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508
[TBL] [Abstract][Full Text] [Related]
28. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
29. Detection of opportunistic DNA viral infections by multiplex PCR among HIV infected individuals receiving care at a tertiary care hospital in South India.
Sachithanandham J; Ramamurthy M; Kannangai R; Daniel HD; Abraham OC; Rupali P; Pulimood SA; Abraham AM; Sridharan G
Indian J Med Microbiol; 2009; 27(3):210-6. PubMed ID: 19584500
[TBL] [Abstract][Full Text] [Related]
30. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
Reading C; Dowding C; Schramm B; Garsd A; Onizuka-Handa N; Stickney D; Frincke J
Clin Microbiol Infect; 2006 Nov; 12(11):1082-8. PubMed ID: 17002607
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
32. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194
[TBL] [Abstract][Full Text] [Related]
33. [Epstein-Barr virus (EBV) infections in patients treated with allogenic hematopoietic cells transplantation (allo-HCT)].
Zawilińska B; Piatkowska-Jakubas B; Kopeć J; Daszkiewicz E; Kleszcz E; Szostek S; Mensah-Glanowska P; Hawrylecka D; Skotnicki A
Przegl Epidemiol; 2006; 60(1):87-92. PubMed ID: 16758744
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
35. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
Mitsuyasu R; Gelman R; Cherng DW; Landay A; Fahey J; Reichman R; Erice A; Bucy RP; Kilby JM; Lederman MM; Hamilton CD; Lertora J; White BL; Tebas P; Duliege AM; Pollard RB;
Arch Intern Med; 2007 Mar; 167(6):597-605. PubMed ID: 17389292
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
38. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
39. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
